However, apart from its early induction in the weight—stable cancer mice, no further increase was observed in SOCS-3 with cachexia progression, highlighting a disconnect between STAT-3 and its downstream negative regulator with chronic IL-6 signaling. The gene discussed is SOCS3; the disease is Cachexia.